These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 21910711)

  • 21. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
    Schmieder GJ; Huang EY; Jarratt M
    J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
    Salido-Vallejo R; Jiménez-Nájar F; Garnacho-Sucedo G; Vélez A
    Arch Dermatol Res; 2020 Nov; 312(9):675-680. PubMed ID: 31838569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT.
    Lee PK; Kloser A
    J Drugs Dermatol; 2013 Aug; 12(8):925-30. PubMed ID: 23986167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.
    Morton C; Campbell S; Gupta G; Keohane S; Lear J; Zaki I; Walton S; Kerrouche N; Thomas G; Soto P;
    Br J Dermatol; 2006 Nov; 155(5):1029-36. PubMed ID: 17034536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial.
    Wiegell SR; Haedersdal M; Eriksen P; Wulf HC
    Br J Dermatol; 2009 Jun; 160(6):1308-14. PubMed ID: 19416257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial comparing 35% trichloroacetic acid peel and 5-aminolaevulinic acid photodynamic therapy for treating multiple actinic keratosis.
    Holzer G; Pinkowicz A; Radakovic S; Schmidt JB; Tanew A
    Br J Dermatol; 2017 May; 176(5):1155-1161. PubMed ID: 28012181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plum-blossom needle tapping enhances the efficacy of ALA photodynamic therapy for facial actinic keratosis in Chinese population: a randomized, multicenter, prospective, and observer-blind study.
    Wang P; Xie F; Zhang L; Zhao S; Zhu L; Shen S; Li D; Chen Z; Xiao R; Lu Y; Lei X; Li Y; Zhang G; Zeng W; Wang X
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103611. PubMed ID: 37211296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of occlusive vs non-occlusive application of 5-aminolevulinic acid (BF-200 ALA) on the efficacy and tolerability of photodynamic therapy for actinic keratosis on the scalp and face: A prospective within-patient comparison trial.
    Meierhofer C; Silic K; Urban MV; Tanew A; Radakovic S
    Photodermatol Photoimmunol Photomed; 2021 Jan; 37(1):56-62. PubMed ID: 32974974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study.
    Szeimies RM; Radny P; Sebastian M; Borrosch F; Dirschka T; Krähn-Senftleben G; Reich K; Pabst G; Voss D; Foguet M; Gahlmann R; Lübbert H; Reinhold U
    Br J Dermatol; 2010 Aug; 163(2):386-94. PubMed ID: 20518784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.
    Togsverd-Bo K; Halldin C; Sandberg C; Gonzalez H; Wennberg AM; Sørensen SS; Wulf HC; Haedersdal M
    Br J Dermatol; 2018 Apr; 178(4):903-909. PubMed ID: 28796885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study.
    Szeimies RM; Matheson RT; Davis SA; Bhatia AC; Frambach Y; Klövekorn W; Fesq H; Berking C; Reifenberger J; Thaçi D
    Dermatol Surg; 2009 Apr; 35(4):586-92. PubMed ID: 19309347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with 5-aminolaevulinic acid methylester is less painful than treatment with 5-aminolaevulinic acid nanoemulsion in topical photodynamic therapy for actinic keratosis.
    Gholam P; Weberschock T; Denk K; Enk A
    Dermatology; 2011; 222(4):358-62. PubMed ID: 21757880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.
    Sotiriou E; Apalla Z; Maliamani F; Zaparas N; Panagiotidou D; Ioannides D
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1061-5. PubMed ID: 19470041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
    Galitzer BI
    J Drugs Dermatol; 2011 Oct; 10(10):1124-32. PubMed ID: 21968662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pain during topical photodynamic therapy - comparing methyl aminolevulinate (Metvix
    Yazdanyar S; Zarchi K; Jemec GBE
    Photodiagnosis Photodyn Ther; 2017 Dec; 20():6-9. PubMed ID: 28780136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial.
    Togsverd-Bo K; Haak CS; Thaysen-Petersen D; Wulf HC; Anderson RR; Hædersdal M
    Br J Dermatol; 2012 Jun; 166(6):1262-9. PubMed ID: 22348388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
    Wiegell SR; Fabricius S; Gniadecka M; Stender IM; Berne B; Kroon S; Andersen BL; Mørk C; Sandberg C; Ibler KS; Jemec GB; Brocks KM; Philipsen PA; Heydenreich J; Hædersdal M; Wulf HC
    Br J Dermatol; 2012 Jun; 166(6):1327-32. PubMed ID: 22250644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Home- vs clinic-based daylight photodynamic therapy with 5-aminolevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis: A randomized, single-blind, prospective study.
    Saenz-Guirado S; Ayen-Rodriguez A; Galvez-Moreno M; Velasco-Amador JP; Llamas-Molina JM; Ruiz-Villaverde R; Molina-Leyva A
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104031. PubMed ID: 38438001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch.
    Hauschild A; Popp G; Stockfleth E; Meyer KG; Imberger D; Mohr P; Itschert G; Kaufmann R; Neuber K; Frambach Y; Gollnick H; Brunnert M; Stocker M; Ortland C; Karrer S
    Exp Dermatol; 2009 Feb; 18(2):116-21. PubMed ID: 18643849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.